Are One or Two Dangerous? Calcium Channel Blocker Exposure in Toddlers

Journal of Emergency Medicine

Volumn 33, Issue 2, 2007, Pages 145-154

  Ranniger, Claudia ^a   Roche, Colleen ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

accidental ingestion; calcium channel blockers; overdose; pediatric; toxicity

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; FELODIPINE; NIFEDIPINE; PHENYLALKYLAMINE; VERAPAMIL;

ARTICLE; BRADYCARDIA; CARDIOVASCULAR EFFECT; CLINICAL OBSERVATION; DEATH; DETOXIFICATION; DISEASE PREDISPOSITION; DRUG INTOXICATION; DRUG RELEASE; EMERGENCY CARE; GASTROINTESTINAL TOXICITY; HOSPITAL CARE; HUMAN; HYPOTENSION; INGESTION; LETHAL DOSE; LETHARGY; PEDIATRICS; PILL; PRESCHOOL CHILD; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; SYMPTOMATOLOGY; TODDLER;

ACCIDENTS, HOME; CALCIUM CHANNEL BLOCKERS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFANT; OVERDOSE;

EID: 34547577282     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2007.02.010     Document Type: Article

References (75)

1. De Roos F. Calcium channel blockers. Goldfrank's toxicologic emergencies. 7th edn. (2002), McGraw-Hill, New York 762-764
2. Litovitz T.L., Klein-Schwartz W., White S., et al. 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 19 (2001) 337-395
3. Abbruzzi G., and Stork C. Pediatric toxicologic concerns. Emerg Med Clin North Am 20 (2002) 223-247
4. Belson M.G., Gorman S.E., Sullivan K., and Geller R.J. Calcium channel blocker ingestions in children. Am J Emerg Med 18 (2000) 581-586
5. Gleyzer A., Traub S., and Hofman R. Calcium channel blocker ingestions in children. Am J Emerg Med 19 (2001) 456-457
6. Koren G. Medications which can kill a toddler with one tablet or teaspoonful. Clin Toxicol 31 (1993) 407-413
7. Osterhoudt K.C., and Henretig F.M. How much confidence that calcium channel blockers are safe?. Vet Hum Toxicol 40 (1998) 239
8. Ramoska E.A., Spiller H.A., and Myers A. Calcium channer blocker toxicity. Ann Emerg Med 19 (1990) 649-653
9. Riggs B.S., Hall A.H., Kulig K.W., et al. Calcium channel blocker ingestion in children: a review of 18 cases. Vet Hum Toxicol 29 (1987) 484
10. Sinaiko A.R., and Daniels S.R. The use of short acting nifedipine in children with hypertension: another example of the need for comprehensive drug testing in children. J Pediatr 139 (2001) 7-9
11. Kerns W., Kline J., and Ford M. Beta blocker and calcium channel blocker toxicity. Emerg Med Clin North Am 12 (1994) 365-389
12. Millard R.W., Lathrop D.A., Grupp G., Ashraf M., Grupp I.L., and Schwartz A. Differential cardiovascular effects of calcium channel blocking agents-potential mechanisms. Am J Cardiol 49 (1982) 499-506
13. Pearigen P.D., and Benowitz N.L. Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine. Drug Saf 6 (1991) 408-430
14. Henry P.D. Comparative pharmacology of calcium antagonists: nifedipine, verapamil, and diltiazem. Am J Cardiol 46 (1980) 1047-1058
15. 2007 Mosby's drug consult. 17th edn. (2006), Mosby, Inc, St. Louis, MO 320-322
16. Schoffstall J.M., Spivey W.H., Gambone L.M., Shaw R.P., and Sit S.P. Effects of calcium channel blocker overdose-induced toxicity in the conscious dog. Ann Emerg Med 20 (1991) 1104-1108
17. Ashraf M., Chaudhary K., Nelson J., and Thompson W. Massive overdose of sustained-release verapamil: a case report and review of literature. Am J Med Sci 310 (1995) 258-263
18. Wax P.M. Intestinal infarction due to nifedipine overdose. J Toxicol Clin Toxicol 33 (1995) 725-728
19. Blaszak R.T., Savage J.A., and Ellis E.N. The use of short-acting nifedipine in pediatric patients with hypertension. J Pediatr 139 (2001) 34-37
20. Flynn J.T., Mottes T.A., Brophy P.D., Kershaw D.B., Smoyer W.E., and Bunchman T.E. Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr 139 (2001) 38-43
21. Flynn J.T., and Pasko D.A. Calcium channel blockers:pharmacology and place in therapy of pediatric hypertension. Pediatr Nephrol 15 (2000) 302-316
22. Gauthier B., and Trachtman H. Short acting nifedipine. Pediatr Nephrol 11 (1997) 786-787
23. Johnson C.E., Jacobson P.A., and Song M.H. Isradipine therapy in hypertensive pediatric patients. Ann Pharmacother 31 (1997) 704-707
24. Khattak S., Rogan J.W., Saunders E.F., Theis J.G., Arbus G.S., and Koren G. Efficacy of amlodipine in pediatric bone marrow transplant patients. Clin Pediatr (Phila) 37 (1998) 31-35
25. Miller K. Pharmacological manageent of hypertension in pediatric patients: a comprehensive review of the efficacy, safety and dosage guidelines of the available agents. Drugs 48 (1994) 868-887
26. Rogan J.W., Lyszkiewicz D.A., Blowey D., Khattak S., Arbus G.S., and Koren G. A randomized prospective crossover trial of amlodipine in pediatric hypertension. Pediatr Nephrol 14 (2000) 1083-1087
27. Siegler R.L., and Brewer E.D. Clinical and laboratory bservations: effect of sublingual or oral nifedipine in the treatment of hypertension. J Pediatr 112 (1988) 811-813
28. Tallian K.B., Nahata M.C., Turman M.A., Mahan J.D., Hayes J.R., and Mentser M.I. Efficacy of amlodipine in pediatric patients with hypertension. Pediatr Nephrol 13 (1999) 304-310
29. Truttmann A.C., Zehnder-Schlapback S., and Bianchetti M.G. A moratorium should be placed on the use of short acting nifedipine for hypertensive crises. Pediatr Nephrol 12 (1998) 259-261
30. Wesseling H., Houwertjes M.C., deLangen C.D., and Kingma J.H. Hemodynamic effects of high dosages of verapamil and the lack of protection by 4-aminopyridine in the rabbit. Arch Int Pharmacodyn Ther 266 (1983) 106-112
31. Strubelt O. Antidotal treatment of the acute cardiovascular toxicity of verapamil. Acta Pharmacol Toxicol (Copenh) 55 (1984) 231-237
32. Egger D.W., Deming D.D., Hamada N., Perkin R.M., and Sahney S. Evaluation of the safety of short-acting nifedipine in children with hypertension. Pedatr Nephrol 17 (2002) 35-40
33. Poisindex Index (2002), Thompson Micromedics September
34. Flynn J.T., Smoyer W.E., and Bunchman T.E. Treatment of hypertensive children with amlodipine. Am J Hypertens 13 (2000) 1061-1066
35. Gomi T., Yamamoto H., Ozeki M., et al. Acute and subacute toxicity of 2,6 dimethyl 3,5-dimethoxycarbonyl-4-(o-difluoromethoxyphenyl)-1,4-dihydropyridine (PP-1466). Arzneimittelforschung 35 (1985) 915-922
36. Chyka P.A., Seger D., Krenzelok E.P., Vale J.A., American Academy of Clinical Toxicology, and European Association of Poison Centres and Clinical Toxicologists. Position paper: single-dose activated charcoal. Clin Toxicol (Phila) 43 (2005) 61-87
37. Laine K., Kivisto K.T., Laakso I., and Neuvonen P.J. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration. Br J Clin Pharmacol 43 (1997) 29-33
38. Laine K., Kivisto K., and Neuvonen P. Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil. Clin Toxicol 35 (1997) 263-268
39. Hendren W.G., Scheiber R.S., and Garrettson L.K. Extracorporeal bypass for the treatment of verapamil poisoning. Ann Emerg Med 18 (1989) 984-987
40. Ramoska E.A., Spiller H.A., Winter M., and Borys D. A one year evaluation of calcium channel blocker overdoses: toxicity and treatment. Ann Emerg Med 22 (1993) 196-200
41. Wells T., Graham C.J., Moss M.M., and Kearns G.L. Nifedepine poisoning in a child. Pediatrics 86 (1990) 91-94
42. Passal D.B., and Crespin F.H. Verapamil poisoning in an infant. Pediatrics 73 (1984) 543-545
43. Litovitz T.L., Schmitz B.F., Matyunas N., and Martin T.G. 1987 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 6 (1988) 479-515
44. Lam Y.M., Tse H.F., and Lau C.P. Continuous calcium chloride infusion for massive nifedipine overdose. Chest 119 (2001) 1280-1282
45. Proano L., Chiang W.K., and Wang R.Y. Calcium channel blocker overdose. Am J Emerg Med 13 (1995) 444-450
46. Stone C.K., May W.A., and Carroll R. Treatment of verapamil overdose with glucagon in dogs. Ann Emerg Med 25 (1995) 369-374
47. Fant J.S., James L.P., Fiser R.T., and Kearns G.L. The use of glucagon in nifedipine poisoning complicated by clonidine ingestion. Pediatr Emerg Care 13 (1997) 417-419
48. Mahr N.C., Valdes A., and Lamas G. Use of glucagon for acute intravenous diltiazem toxicity. Am J Cardiol 79 (1997) 1570-1571
49. Papadopoulos J., and O'Neil M.G. Utilization of a glucagon infusion in the management of a massive nifedipine overdose. J Emerg Med 18 (2000) 453-455
50. Sheperd G., and Klein-Schwartz W. High-dose insulin therapy for calcium-channel blocker overdose. Ann Pharmacother 39 (2005) 923-930
51. Yuan T.H., Kerns II W.P., Tomaszewski C.A., Ford M.D., and Kline J.A. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol 37 (1999) 463-474
52. Lee D.C., Greene T., Dougherty T., and Pearigan P. Fatal nifedipine ingestions in children. J Emerg Med 19 (2000) 359-361
53. Brayer A.F., and Wax P. Accidental ingestion of sustained release calcium channel blockers in children. Vet Hum Toxicol 40 (1998) 104-106
54. Litovitz T.L., Holm K.C., Bailey K.M., and Schmitz B.F. 1991 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 10 (1992) 452-505
55. Pearigan P.D. Death from accidental nifedipine ingestion in a toddler. (abstract). Vet Hum Toxicol 35 (1993) 345
56. Litovitz T.L., Holm K.C., Clancy C., Schmitz B.F., Clark L.R., and Odera G.M. 1992 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 11 (1993) 494-555
57. Watson W., Litovitz T., Rodgers G., et al. 2002 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 21 (2003) 353-421
58. Greene T.G., Dougherty T., and Purnell G.V. Fatal nifedipine ingestion. (abstract). J Toxicol Clin Toxicol 35 (1997) 495
59. Litovitz T.L., Felberg L., Soloway R.A., Ford M., and Geller R. 1994 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 13 (1995) 551-597
60. Litovitz T.L., Normann S.A., and Veltri J.C. 1985 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 4 (1986) 427-458
61. Litovitz T.L., Smilkstein M., Felberg L., Klein-Schwartz W., Berlin R., and Morgan J.L. 1996 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 15 (1997) 447-500
62. Litovitz T.L., Clark L.R., and Soloway R.A. 1993 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 12 (1994) 546-584
63. Litovitz T.L., Klein-Schwartz W., White S., et al. 1999 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 18 (2000) 517-574
64. Spiller H.A., and Ramoska E.A. Isradipine ingestion in a two-year-old child. Vet Hum Toxicol 35 (1993) 233
65. Litovitz T.L., Schmitz B.F., and Holm K.C. 1988 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 7 (1989) 495-545
66. Watson W., Litovitz T., Rodgers G., et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 23 (2005) 589-666
67. Litovitz T.L., and Veltri J.C. 1984 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 3 (1985) 423-450
68. Litovitz T.L., Schmitz B.F., and Bailey K.M. 1989 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 8 (1990) 394-442
69. Morris-Kukoski C., Biswas A., and Para M. Insulin 'euglycemia' for accidental nifedipine overdose. J Toxicol Clin Toxicol 38 (2000) 577
70. Linakis J.G., and Frederick K.A. Poisoning deaths not reported to the regional poison control center. Ann Emerg Med 22 (1993) 1822-1828
71. Roper T.A., Sykes R., and Gray C. Fatal diltiazem overdose: report of four cases and review of the literature. Postgrad Med J 69 (1993) 474-476
72. Olson K.R., Erdman A.R., Woolf A.D., et al. Calcium channel blocker ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 43 (2005) 797-822
73. Howarth D.M., Dawson A.H., Smith A.J., Buckley N., and Whyte I.M. Calcium channel blocking drug overdose: an Australian series. Hum Exp Toxicol 13 (1994) 161-166
74. Sauder P., Kopferschmitt J., Dahlet M., et al. Acute verapamil poisoning: 6 cases and review of literature. [French]. J Toxicol Clin Exp 10 (1990) 261-270
75. Hofer C.A., Smith J.K., and Tenholder M.F. Verapamil intoxication: a literature review of overdoses and discussion of therapeutic options. Am J Med 95 (1993) 431-438